| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |